Debt-to-equity in % of Ocean Biomedical, Inc. from Q2 2022 to Q1 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Ocean Biomedical, Inc. quarterly Debt-to-equity history and change rate from Q2 2022 to Q1 2025.
  • Ocean Biomedical, Inc. Debt-to-equity for the quarter ending 31 Mar 2025 was -101 %, a 2.3% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Ocean Biomedical, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q1 2025 -101 +2.39 +2.3% 31 Mar 2025
Q4 2024 -102 +1.3 +1.26% 31 Dec 2024
Q3 2024 -103 -0.58 -0.57% 30 Sep 2024
Q2 2024 -103 -3.6 -3.61% 30 Jun 2024
Q1 2024 -104 -13.6 -15.1% 31 Mar 2024
Q4 2023 -103 -37.4 -56.7% 31 Dec 2023
Q3 2023 -103 -56.3 -121% 30 Sep 2023
Q2 2023 -99.8 -46 -85.4% 30 Jun 2023
Q1 2023 -90.2 31 Mar 2023
Q4 2022 -65.8 31 Dec 2022
Q3 2022 -46.4 30 Sep 2022
Q2 2022 -53.8 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.